For example, FasL and TRAIL do not effectively signal apoptosis in some tumour cells (Mace et al, 2006), and therefore targeting the perforin/granzyme-B mechanism may be essential to immunological antitumour activity in these cases. Here, PRF1 is linked to neoplasm.